Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

63results about How to "Suitable for process production" patented technology

Medicinal salts of saxagliptin and preparation methods of medicinal salts

The invention provides medicinal salts of saxagliptin, and particularly relates to mesylate, meleate, malate, succinate and citrate as well as preparation methods of the medicinal salts. The medicinal salts have the advantage of good stability, and are not easy to degrade. Preparations with controllable quality and low cost, which are suitable for industrial production, are prepared from the medicinal salts and pharmaceutically acceptable carriers through a conventional preparation technology. The medicinal salts can be used for treating and / or preventing diabetes mellitus.
Owner:廖国超

Immunomodulator slow-release preparation and preparation method thereof

The invention discloses an immunomodulator slow-release preparation and a preparation method thereof. A lenalidomide slow-release tablet is composed of a slow-release layer and an optional quick-release layer, wherein the slow-release layer contains active ingredients of lenalidomide and a slow-release framework material simultaneously; the quick-release layer does not contain the slow-release framework material. The lenalidomide slow-release tablet disclosed by the invention is capable of slowly and uniformly releasing medicines by virtue of the slow-release framework material, so as to reduce the release speed, delay the time to peak, prolong the action time of lenalidomide, and provide a uniform and constant blood concentration. Moreover, The lenalidomide slow-release tablet disclosed by the invention is simple in prescription and excellent in quality stability; the preparation process is simple to operate, free from special treatment and production equipment, low in production cost, and beneficial to batch-enlarged industrial production for the product; the preparation method is high in yield, the granulation and crushing procedures are simple and practicable to operate, the intermediate material is good in stability, flowability, compressibility and content uniformity, and completely meets the requirements of tabletting, and the surface of the prepared tablet is smooth and beautiful.
Owner:AC PHARMA CO LTD

Imatinib mesylate polymorph and pharmaceutical composition

ActiveCN102070605ANot suitable for the needs of large-scale and stable productionSimple preparation processOrganic active ingredientsSenses disorderImatinib mesylateMedicine
The invention discloses an imatinib mesylate polymorph I, which is a typical X-ray diffraction pattern and has a diffraction peak at 2theta of 17.7+ / -0.2 degrees, 18.1+ / -0.2 degrees, 18.6+ / -0.2 degrees, 19.1+ / -0.2 degrees, 19.7+ / -0.2 degrees and 20.4+ / -0.2 degrees. In addition, the invention also discloses a preparation method thereof and a pharmaceutical composition. The imatinib mesylate polymorph I has the advantages of high purity, excellent physicochemical property and high stability, and is more suitable for industrial mass production.
Owner:NANJING CAVENDISH BIO ENG TECH +1

Method for improving yield and trace element enrichment of liquid fermentation mycelium of lucid ganoderma

The invention relates to the field of liquid fermentation mycelium of lucid ganoderma and provides a method for improving yield and trace element enrichment of the liquid fermentation mycelium of the lucid ganoderma. The method is characterized by comprising the steps of inoculating a slope lucid ganoderma strain onto a liquid seed culture medium added with trace element-containing substances, performing mutation breeding by ultraviolet rays and cobalt-60 gamma rays, placing the lucid ganoderma mycelium into a fermentation tank for expansion breeding step by step, and performing separation filtering, vacuum microwave drying and crushing on the lucid ganoderma mycelium to obtain a product. The method adopts the fermentation process controlled by adopting pH value steady state feedback step by step according to the composition and distribution of the trace elements in the culture medium, thus more facilitating improving the conversion efficiency of multiple trace elements; the process is efficient and controllable, and the mycelium is high in additional value and suitable for process production; and the drying method for the mycelium adopts hot wind combined with a vacuum microwave drying technology and keeps the biological activity of effective constituents in the mycelium.
Owner:HUBEI JIAFU BIOLOGICAL TECH

Pharmaceutical composition of ornithine aspartate

The invention discloses a pharmaceutical composition of ornithine aspartate. By fusing, mixing and preparing ornithine aspartate and a proper amount of PLGA and PEG6000, the ideal slow-release effectcan be achieved. The pharmaceutical preparation prepared from the pharmaceutical composition of ornithine aspartate is slowly released, a patient just needs to take the medicine once a day, the patient compliance is high, the stable blood concentration can be maintained, the side effect is small, and the effect is good; the consumption of auxiliary materials is low, the preparation technology is simple, and the composition is suitable for technological production.
Owner:YANGTZE RIVER PHARM GRP GUANGZHOU HAIRUI PHARM CO LTD +1

Dopamine prodrug composition and preparation method thereof

The invention relates to a dopamine prodrug composition and a preparation method of the dopamine prodrug composition. The invention provides a pharmaceutical composition of dopamine prodrug, and the composition comprises the dopamine prodrug, benserazide hydrochloride, an adhesive, a stabilizer and a pharmaceutically acceptable carrier. The pharmaceutical composition containing the dopamine prodrug provided by the invention has excellent stability and does not occur color change, and is capable of effectively guaranteeing that the product quality meets a quality standard requirement within a storage period. The pharmaceutical composition containing the dopamine prodrug provided by the invention has a simple prescription, and auxiliary materials are cheap and available with a small amount; the preparation process provided by the invention is simple and easy to control, used devices are the most conventional workshop production devices, the cost is low, and the preparation process is suitable for industrial production.
Owner:SHANGHAI SINE PHARMA LAB

Production technology of black soybean vinegar

InactiveCN107904124ASolve problems that cannot be fully releasedPromote dissolutionVinegar preparationYeastDissolution
The invention belongs to the technical field of food processing and in particular relates to a production technology of black soybean vinegar. The production technology comprises the following steps:firstly, weighing a black soybean mixture, wheat, sorghum rice, peas, smashed bran, cavings and yeast for making hard liquor in proportion; secondly, putting black soybeans, the wheat, the sorghum rice, the peas, the smashed bran and the cavings into a steamer, and steaming for 120 minutes; thirdly, putting cooked raw materials into a fermentation tank, spreading out and cooling, then pouring intothe yeast for making the hard liquor and stirring, and then carrying out constant temperature fermentation for 15 days; fourthly, putting the fermented raw materials into a smoke baking tank, and carrying out smoke baking for 15 days; and fifthly, pouring vinegar on the raw materials subjected to the smoke baking, and then carrying out grooving and grouting conservation or bottling by virtue of apipeline. The production technology provided by the invention has the advantages that the problem that the black soybeans can not be fully released in the prior art is solved, and a black soybean vinegar soaking technology can be effectively replaced, so that dissolution of nutrient substances of the black soybeans can be effectively enhanced, and taste and flavor are also improved.
Owner:靖江市圣材食品有限公司

High-capacity pulse-activating injection and preparation method thereof

The invention discloses a high-capacity pulse-activating injection and a preparation method thereof. The preparation method comprises the following steps of with red ginseng, radix ophiopogonis and schisandra chinensis as raw materials, preparing by using a modern extracting and purifying method to obtain an active part with high effective ingredient content and low impurity component content; then, adding glucose or sodium chloride; and diluting the active part into the injection with the specification of 100-500ml by using water for injection. The high-capacity pulse-activating injection provided by the invention can be directly used for infusion, can be used for avoiding secondary pollution during liquid preparation, and is particularly good in stability and high in safety performance in clinic application; and the preparation method is reasonable in process design and suitable for large-scale industrial production.
Owner:常熟雷允上制药有限公司

Novel intermediate of palbociclib, and crystal form and preparation method of novel intermediate

InactiveCN111892590ALow costEasy to crystallize and good stabilityOrganic chemistry methodsPyrimidinePalbociclib
The invention belongs to the technical field of medicinal chemistry, and particularly relates to a novel intermediate of palbociclib, namely 4-(6-(8-cyclopentyl-5-methyl-7-oxo-6-(1-propoxyvinyl)-7,8-dihydropyrido[2, 3-d]pyrimidin-2-ylamino)pyridin-3-yl)-piperazinyl-1-carboxylic acid tert-butyl ester, and a crystal form and a preparation method of the novel intermediate. The method is simple in technological operation and post-treatment, a crystallization solvent is easy to recycle, cost is low, and the obtained intermediate is easy to crystallize, good in stability, good in purity, high in yield and more suitable for industrial production.
Owner:QILU PHARMA

7-ethyl-10-hydroxycamptothecine crystal forms, and preparation method and application thereof

ActiveCN104557961ACrystal form with high solubilityEasy to prepareOrganic active ingredientsOrganic chemistrySolubilityX-ray
The invention relates to 7-ethyl-10-hydroxycamptothecine crystal forms II and III, and a preparation method and application thereof. The crystal form II uses Cu-K alpha radiation; the X-ray powder diffraction represented by 2theta angle has characteristic peaks when the diffraction angle is 5.64, 10.80, 12.55, 13.48, 17.09, 17.65, 18.21, 18.79, 24.52 and 26.84 degrees; and the error range of 2theta is + / -0.2 degree. The crystal form III uses Cu-K alpha radiation; the X-ray powder diffraction represented by 2theta angle has characteristic peaks when the diffraction angle is 4.58, 9.34, 10.42, 11.12, 12.30, 13.40, 14.40, 16.34, 16.86, 17.20, 17.70, 18.72, 19.32, 21.48, 22.44, 24.90, 25.40, 25.68 and 27.44 degrees; and the error range of 2theta is + / -0.2 degree. The two crystal forms of 7-ethyl-10-hydroxycamptothecine have high solubility and favorable stability.
Owner:SHANDONG UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products